“Cost-Benefit Analysis of the Pigmented Lesion Assay When Introduced Into the Visual Assessment Histopathology Pathway for Lesions Clinically Suspicious for Melanoma”. SKIN The Journal of Cutaneous Medicine 6, no. 2 (March 4, 2022): 109–121. Accessed May 26, 2026. https://skin.dermsquared.com/skin/article/view/1475.